These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2026988)

  • 1. Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients.
    Launbjerg J; Egeblad H; Heaf J; Nielsen NH; Fugleholm AM; Ladefoged K
    J Intern Med; 1991 Apr; 229(4):351-5. PubMed ID: 2026988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Avoiding emergency situations under anticoagulant therapy with vitamin K antagonists].
    Dempfle CE; Borggrefe M
    Internist (Berl); 2005 Sep; 46(9):1006-10, 1012-3. PubMed ID: 16082525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrointestinal bleeding risk of non-vitamin K oral anticoagulants is similar to warfarin - a Japanese retrospective cohort study
.
    Shirai T; Yamamoto T; Kawasugi K; Kuyama Y; Kita H
    Int J Clin Pharmacol Ther; 2016 Nov; 54(11):841-846. PubMed ID: 27569738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
    Bouillon K; Bertrand M; Maura G; Blotière PO; Ricordeau P; Zureik M
    Lancet Haematol; 2015 Apr; 2(4):e150-9. PubMed ID: 26687957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists.
    Di Nisio M; Raskob G; Büller HR; Grosso MA; Zhang G; Winters SM; Cohen A
    Thromb Haemost; 2017 Apr; 117(4):784-793. PubMed ID: 28151543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of vitamin K antagonists and risk of subarachnoid haemorrhage: a population-based case-control study.
    Olsen M; Johansen MB; Christensen S; Sørensen HT
    Eur J Intern Med; 2010 Aug; 21(4):297-300. PubMed ID: 20603039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors of serious bleeding among ambulatory patients taking antivitamin K aged 75 and over].
    Blas-Châtelain C; Chauvelier S; Foti P; Debure C; Hanon O
    J Mal Vasc; 2014 May; 39(3):169-77. PubMed ID: 24679962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study.
    Yagyuu T; Kawakami M; Ueyama Y; Imada M; Kurihara M; Matsusue Y; Imai Y; Yamamoto K; Kirita T
    BMJ Open; 2017 Aug; 7(8):e015952. PubMed ID: 28827248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study).
    Green L; Tan J; Morris JK; Alikhan R; Curry N; Everington T; Maclean R; Saja K; Stanworth S; Tait C; MacCallum P
    Haematologica; 2018 Apr; 103(4):738-745. PubMed ID: 29371325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
    Pritchard ER; Murillo JR; Putney D; Hobaugh EC
    J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes.
    Meegaard PM; Holck LH; Pottegård A; Madsen H; Hallas J
    Dan Med J; 2012 Feb; 59(2):A4383. PubMed ID: 22293053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management.
    Pautas E; Gouin-Thibault I; Debray M; Gaussem P; Siguret V
    Drugs Aging; 2006; 23(1):13-25. PubMed ID: 16492066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.
    van der Meer FJ; Rosendaal FR; Vandenbroucke JP; Briët E
    Arch Intern Med; 1993 Jul; 153(13):1557-62. PubMed ID: 8323419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous and non-spontaneous bleeding complications in patients with oral vitamin K antagonist therapy.
    Hoffmann M; Zimmermann M; Meyer R; Laubert T; Begum N; Keck T; Kujath P; Schloericke E
    Langenbecks Arch Surg; 2014 Jan; 399(1):99-107. PubMed ID: 24306104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative risks of bleeding, ischemic stroke and mortality with direct oral anticoagulants versus phenprocoumon in patients with atrial fibrillation.
    Ujeyl M; Köster I; Wille H; Stammschulte T; Hein R; Harder S; Gundert-Remy U; Bleek J; Ihle P; Schröder H; Schillinger G; Zawinell A; Schubert I
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1317-1325. PubMed ID: 29909576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists.
    Becattini C; Franco L; Masotti L; Nitti C; Cattinelli S; Cappelli R; Manina G; Sbrojavacca R; Pomero F; Agnelli G
    Eur J Intern Med; 2016 Sep; 33():47-54. PubMed ID: 27289494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berrettini M; Musolesi S
    Lancet; 1996 Aug; 348(9025):423-8. PubMed ID: 8709780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding risks associated with vitamin K antagonists.
    Linkins LA
    Blood Rev; 2013 May; 27(3):111-8. PubMed ID: 23473948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
    Melkonian M; Jarzebowski W; Pautas E; Siguret V; Belmin J; Lafuente-Lafuente C
    J Thromb Haemost; 2017 Jul; 15(7):1500-1510. PubMed ID: 28393461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.